Holding website 
- About Us
- APR Products
- Our Services
- Media
- Contacts
Discover who we are and our partners global network, as well as learn more about our people.
Learn more about our products and how they provide innovative solutions for patiens' unmet needs.
Discover our capabilities in project design services.
Find information such as website news, press releases and event presentations.
Get in touch with us to set up a meeting or propose your cooperation.
The cancer supportive care products market, estimated to be worth $13.8 billion in 2006, is growing rapidly due to the:
Patients worldwide have increasing needs for treatment of nausea and vomiting, especially as part of cancer therapy. A recent market report forecasts the world market for antiemetic drugs will reach $4.6 billion in 2018, rising further to 2024 due to the global rise in cancer levels - cancer treatment is the leading cause of nausea and vomiting.
To encourage treatment compliance, drug companies are developing antiemetic therapies with novel delivery methods.
Oncodermatology (dermatologic adverse events due to cancer therapy) investigations show that 40-90% of patients taking targeted oncological therapies experience skin toxicities, costing an average of $2000/patient.
Oncodermatological side-effects can lead to interruption of treatment, thereby reducing efficacy and incurring extra costs.
